Episode

PPP 193 - Childhood Cancer in First Nations People with Dr Jessica Buck

Podcast
Purple Pen Podcast
Published
Jul 5, 2026
Duration seconds
1899
Processing state
not_requested
Canonical source
https://www.purplepenpodcast.com/
Audio
https://traffic.libsyn.com/secure/purplepenpodcast/Childhood_Cancer.mp3?dest-id=433310
JSON
/v1/public/podcasts/purple-pen-podcast-53605/episodes/ppp-193-childhood-cancer-in-first-nations-people-with-dr-jessica-buck
Markdown
/podcast/purple-pen-podcast-53605/ppp-193-childhood-cancer-in-first-nations-people-with-dr-jessica-buck.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/purple-pen-podcast-53605/episodes/ppp-193-childhood-cancer-in-first-nations-people-with-dr-jessica-buck/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/purple-pen-podcast-53605/ppp-193-childhood-cancer-in-first-nations-people-with-dr-jessica-buck.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

To align with NAIDOC week this year we have a special bonus episode. In this episode, we speak with Dr Jessica Buck about childhood cancer in First Nations people, genomics, and the importance of cultural safety in healthcare and research. A proud Kamilaroi woman, she is the Team Leader of the First Nations Childhood Cancer Program at The Kids Research Institute Australia — a first-of-its-kind initiative dedicated to developing culturally safe, community-led research strategies to improve outcomes for First Nations children with cancer. Together, we explore how a First Nations perspective can strengthen biomedical science and improve care for Aboriginal and Torres Strait Islander children and families affected by cancer. We cover: What culturally safe healthcare and research look like in practice Applying a First Nations lens to genomics and biomedical science How historical harms in healthcare and research continue to influence trust today Childhood cancer outcomes for First Nations children The impact of geography, access to care, racism and broader inequities Why representation in genomic databases and clinical trials matters The clinical implications of underrepresentation for diagnosis and treatment The potential role of pharmacogenomics in cancer care Treatment-related adverse effects Opportunities to improve equity in childhood cancer care Further reading and resources: Clark (Adnyamathanha), J.R., Buck (Kamilaroi), J., Richards-Satour (Adnyamathanha and Barngarla), A., Lyons (Jaadwa), L. and Brown (Yuin), A. (2024), Towards precision cancer medicine for Aboriginal and Torres Strait Islander cancer health equity. Med J Aust, 221: 68-73. https://doi.org/10.5694/mja2.52346 https://onlinelibrary.wiley.com/doi/10.5694/mja2.52346 Alexandra Truong, Kayla Williams‐Tuck…